A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer.
Autor: | Hussain, S. A.1,2 hussainsa@cancer.bham.ac.uk, Stocken, D. D.1, Riley, P.2, Palmer, D. H.1,2, Peake, D. R.2, Geh, J. I.2, Spooner, D.2, James, N. D.1,2 |
---|---|
Zdroj: | British Journal of Cancer. 8/31/2004, Vol. 91 Issue 5, p844-849. 6p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |